Sign in to view content

Treatment of Geographic Atrophy Secondary to AMD With Pegcetacoplan: Two-Year Outcomes From the Randomized Phase 3 DERBY and OAKS Trials

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2022

Related

Fovea-Sparing Rhegmatogenous Retinal Detachments: Impact of Clinical Factors Including Time to Surgery on Visual and Anatomic Outcomes
James C. Major, MD, PhD FACS FASRS
Annual Meeting Talks
2019
Preservation of Vision by ANX007: Clinical Results and Anatomic Changes From the Phase 2 ARCHER Trial
Joel Pearlman, MD, PhD
Annual Meeting Talks
2024
Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD
Peter A. Campochiaro, MD
Updates from the Field
2020

Category: Age-Related Macular Degeneration

See more